Deletion of pancreas-specific miR-216a reduces beta-cell mass and inhibits pancreatic cancer progression in mice.

MLA

Erener, Suheda, et al. “Deletion of Pancreas-Specific MiR-216a Reduces Beta-Cell Mass and Inhibits Pancreatic Cancer Progression in Mice.” Cell Reports. Medicine, vol. 2, no. 11, Nov. 2021, p. 100434. EBSCOhost, https://doi.org/10.1016/j.xcrm.2021.100434.

APA

Erener, S., Ellis, C. E., Ramzy, A., Glavas, M. M., O’Dwyer, S., Pereira, S., Wang, T., Pang, J., Bruin, J. E., Riedel, M. J., Baker, R. K., Webber, T. D., Lesina, M., Blüher, M., Algül, H., Kopp, J. L., Herzig, S., & Kieffer, T. J. (2021). Deletion of pancreas-specific miR-216a reduces beta-cell mass and inhibits pancreatic cancer progression in mice. Cell Reports. Medicine, 2(11), 100434. https://doi.org/10.1016/j.xcrm.2021.100434

Chicago

Erener, Suheda, Cara E Ellis, Adam Ramzy, Maria M Glavas, Shannon O’Dwyer, Sandra Pereira, Tom Wang, et al. 2021. “Deletion of Pancreas-Specific MiR-216a Reduces Beta-Cell Mass and Inhibits Pancreatic Cancer Progression in Mice.” Cell Reports. Medicine 2 (11): 100434. doi:10.1016/j.xcrm.2021.100434.